查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446504

定序市场规模、份额和趋势分析报告：按产品/服务、应用、工作流程、最终用途、区域和细分市场进行预测，2024-2030 年

Sequencing Market Size, Share & Trends Analysis Report By Product & Services (Platform, Software), By Application (Oncology, Clinical Investigation), By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

定序市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2030年全球定序市场规模将达到624.8亿美元，2024年至2030年复合年增长率为22.2%。

政府和私人组织对基因组研究和开发的投资增加，以及对个人化医疗和精准治疗的需求不断增长，预计将导致这些技术的采用增加，进一步提振市场。例如，2022年12月，英国政府宣布将与国家医疗服务体系（NHS）合作投资2.2236亿美元用于基因组研究。该投资旨在探索利用全基因组定序治疗和发现新生儿罕见遗传疾病的有效性。

曲状桿菌感染疾病、甲型肝炎、B型肝炎、C型肝炎、爱滋病毒、流感和脑膜炎球菌病菌感染等感染疾病发病率的上升是市场的主要驱动因素。据世界卫生组织称，到 2022 年，将有 3900 万人感染爱滋病毒。据乙型肝炎基金会称，每年约有 150 万人新感染B型肝炎。随着疫情和传染病的增加，对准确、快速定序技术的需求不断增长，以帮助识别导致这些疾病的病原体。技术的进步使得对病原体基因组序列测定变得更加容易和快捷，使医疗保健提供者和研究人员能够更好地了解这些疾病的传播并开发有针对性的治疗方法和疫苗。我现在可以做到。因此，由于预防感染疾病和改善全球健康的需要，预计该市场将继续成长。

COVID-19大流行对市场产生了重大影响。病毒的快速传播增加了对这些技术的需求，以便更好地了解病毒并追踪其突变。这导致对测序设备、试剂和服务的需求激增。然而，这种流行病也对市场成长产生了负面影响，因为它扰乱了供应链并导致研究计划延迟。

该市场面临一些挑战，包括与定序和资料分析相关的高成本、这些技术的准确性和可靠性的限制，以及管理和解释定序产生的大量资料的困难。此外，人们也担心与基因资讯定序相关的资料隐私和伦理影响。仍需要标准化和控制定序品管，提高研究人员和临床医生的可及性，并使其更便宜。

定序市场报告亮点

  • 消耗品在产品和服务领域占据主导地位，到 2023 年，其份额将超过 44.5%，因为研究和诊断领域不断增长的定序需求正在推动新型和改进消耗品的开发。
  • 从应用领域来看，2023年肿瘤学占最大市场占有率。同时，总体基因体学、流行病学和药物开发预计将以最快的复合年增长率成长。
  • 到 2023 年，定序预计将在工作流程领域占据主导地位，资料分析将以最快的复合年增长率成长。
  • 在推进知识和为科学利益做出贡献的愿望的推动下，学术研究带来了更多的创新研究，在 2023 年获得最大份额并主导最终用途领域。
  • 北美以49.4%的市占率主导定序市场。这是由于高感染疾病负担、高购买力平价、政府对优质医疗保健的支持、可报销等因素所造成的。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章市场变数、趋势和范围

  • 市场区隔和范围
  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 产业分析工具
    • SWOT 分析；按因素（政治/法律、经济/技术）
    • 波特五力分析
    • COVID-19感染疾病的影响分析

第四章定序市场：产品与服务的业务分析

  • 定序市场：产品和服务的市场占有率分析
  • 按产品和服务
  • 平台
  • 消耗品
  • 服务
  • 软体

第五章定序市场：应用业务分析

  • 定序市场：应用市场占有率分析
  • 按用途
  • 肿瘤学
  • 临床调查
  • 生殖健康
  • HLA型检测/免疫系统监测
  • 总体基因体学、流行病学、药物发现
  • 农业基因组学与法医学
  • 消费者基因体学

第六章定序市场：工作流程业务分析

  • 定序市场：工作流程市场占有率分析
  • 按工作流程
  • 前序
  • 顺序
  • 资料分析

第七章定序市场：最终用途业务分析

  • 定序市场：最终用途市场占有率分析
  • 按最终用途
  • 学术研究
  • 临床调查
  • 医院和诊所
  • 製药和生物技术公司
  • 其他用户

第八章定序市场：区域业务分析

  • 2023 年及 2030 年按地区定序市场占有率
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第9章 竞争形势

  • 财务绩效
  • 参与企业
    • 市场领导者
  • 参与企业概况
    • Illumina, Inc.
    • F. Hoffman-La Roche Ltd.
    • QIAGEN
    • Thermo Fisher Scientific, Inc.
    • Bio-Rad Laboratories, Inc.
    • Oxford Nanopore Technologies
    • PierianDx
    • Genomatix GmbH
    • DNASTAR, Inc.
    • Perkin Elmer, Inc.
    • Eurofins GATC Biotech GmbH
    • BGI
  • 策略规划
    • 扩张
    • 获得
    • 合作
    • 产品/服务发布
    • 合伙
    • 其他的
Product Code: GVR-4-68040-195-0

Sequencing Market Growth & Trends:

The global sequencing market size is anticipated to reach USD 62.48 billion by 2030, growing at a CAGR of 22.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing investments by governments and private organizations in genomic research and development and the increasing demand for personalized medicine and precision treatments have led to a rise in the adoption of these technologies, which are expected to boost the market further. For instance, in December 2022, the UK government announced a USD 222.36 million investment in genomics research in partnership with the National Health Service (NHS). This investment aimed to explore the effectiveness of using whole-genome sequencing to treat and find rare genetic diseases in newborn babies.

The rising number of infectious diseases such as Campylobacter infection, Hepatitis A, B, C, HIV, Influenza (Flu), and Meningococcal disease has been a major driver of the market. According to WHO, in 2022, 39 million people are living with HIV. As per the Hepatitis B Foundation, approximately 1.5 million people are newly infected due to hepatitis B each year. As the number of outbreaks and epidemics increases, there is a growing demand for accurate and rapid sequencing technologies that can help identify the pathogens responsible for these diseases. With the advancement of technologies, it has become easier and faster to sequence the genomes of pathogens, enabling healthcare providers and researchers to understand the spread of these diseases better and develop targeted treatments and vaccines. As a result, the market is expected to continue to grow in the coming years, driven by the need to combat infectious diseases and improve global health.

The COVID-19 pandemic has had a significant impact on the market. With the rapid spread of the virus, there has been an increased demand for these technologies to understand the virus better and track its mutations. This has led to a surge in demand for sequencing instruments, reagents, and services. However, the pandemic has also disrupted supply chains and caused delays in research projects, which has had a negative impact on the market growth.

The market faces several challenges, including high costs associated with sequencing and data analysis, limited accuracy and reliability of these technologies, and difficulties in managing and interpreting large amounts of data generated by sequencing. In addition, there are concerns regarding data privacy and ethical implications related to sequencing genetic information. There is still a need for standardization and quality control in sequencing, improved accessibility, and affordability for researchers and clinicians.

Sequencing Market Report Highlights:

  • Consumables dominated the product & service segment with more than 44.5% share in 2023 owing to the increasing demand for sequencing in research and diagnostics, which has resulted in the development of new and improved consumables
  • In application segment, oncology held the largest market share in 2023. On the other hand, metagenomics, epidemiology & drug development is expected to grow at the fastest CAGR
  • In 2023, sequencing dominated the workflow segment, and data analysis is expected to at the fastest CAGR
  • Academic research dominated the end-use segment with largest share in 2023 driven by a desire to advance knowledge and contribute to scientific interests, resulting in more innovative research
  • North America dominated the sequencing market with a share of 49.4% owing to factors such as the significant burden of infectious diseases, high purchasing power parity, government support for quality healthcare, and availability of reimbursement

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Application
    • 1.2.3. Workflow
    • 1.2.4. End-use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing Cases of Cancer
      • 3.3.1.2. Technological advances in next-generation sequencing technologies
      • 3.3.1.3. High investment in research and development
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Lack of Skilled Professionals
      • 3.3.2.2. Legal and Ethical Issues
  • 3.4. Industry Analysis Tools
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Sequencing market: Product & Services Business Analysis

  • 4.1. Sequencing market: Product & Services Market Share Analysis
  • 4.2. Sequencing market Estimates & Forecast, By Product & Services (USD Million)
  • 4.3. Platform
    • 4.3.1. Global Platform Market, 2018 - 2030 (USD Million)
    • 4.3.2. 1st Generation of Sequencing Device
      • 4.3.2.1. Global 1st Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
    • 4.3.3. 2nd Generation of Sequencing Device
      • 4.3.3.1. Global 2nd Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
    • 4.3.4. 3rd Generation of Sequencing Device
      • 4.3.4.1. Global 3rd Generation of Sequencing Device Market, 2018 - 2030 (USD Million)
  • 4.4. Consumables
    • 4.4.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 4.4.2. Kits
      • 4.4.2.1. Global Kits Market, 2018 - 2030 (USD Million)
      • 4.4.2.2. DNA Library Preparation
      • 4.4.2.2.1. Global DNA Library Preparation Market, 2018 - 2030 (USD Million)
      • 4.4.2.3. RNA Library Preparation
      • 4.4.2.3.1. Global RNA Library Preparation Market, 2018 - 2030 (USD Million)
      • 4.4.2.4. Target enrichment
      • 4.4.2.4.1. Global Target enrichment Market, 2018 - 2030 (USD Million)
      • 4.4.2.5. Library quantification
      • 4.4.2.5.1. Global Library quantification Market, 2018 - 2030 (USD Million)
      • 4.4.2.6. Purification & quality control
      • 4.4.2.6.1. Global Purification & quality control Market, 2018 - 2030 (USD Million)
      • 4.4.2.7. Others
      • 4.4.2.7.1. Global Others Market, 2018 - 2030 (USD Million)
    • 4.4.3. Reagents
      • 4.4.3.1. Global Reagents Market, 2018 - 2030 (USD Million)
      • 4.4.3.2. Sample Prep
      • 4.4.3.2.1. Global Sample Prep Market, 2018 - 2030 (USD Million)
      • 4.4.3.3. Library preparation and amplification
      • 4.4.3.3.1. Global Library preparation and amplification Market, 2018 - 2030 (USD Million)
      • 4.4.3.4. Sequencing
      • 4.4.3.4.1. Global Sequencing Market, 2018 - 2030 (USD Million)
    • 4.4.4. Accessories
      • 4.4.4.1. Global Accessories Market, 2018 - 2030 (USD Million)
      • 4.4.4.2. Collection tubes
      • 4.4.4.2.1. Global Collection tubes Market, 2018 - 2030 (USD Million)
      • 4.4.4.3. Plates
      • 4.4.4.3.1. Global Plates Market, 2018 - 2030 (USD Million)
      • 4.4.4.4. Others
      • 4.4.4.4.1. Global Others Market, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Global Services Market, 2018 - 2030 (USD Million)
  • 4.6. Software
    • 4.6.1. Global Software Market, 2018 - 2030 (USD Million)

Chapter 5. Sequencing Market: Application Business Analysis

  • 5.1. Sequencing Market: Application Market Share Analysis
  • 5.2. Sequencing Market Estimates & Forecast, By Application (USD Million)
  • 5.3. Oncology
    • 5.3.1. Global Oncology Market, 2018 - 2030 (USD Million)
    • 5.3.2. Diagnostics and Screening
      • 5.3.2.1. Global Diagnostics and Screening Market, 2018 - 2030 (USD Million)
    • 5.3.3. Oncology Screening
      • 5.3.3.1. Global Oncology Screening Market, 2018 - 2030 (USD Million)
      • 5.3.3.1.1. Sporadic Cancer
      • 5.3.3.1.1.1. Global Sporadic Cancer Market, 2018 - 2030 (USD Million)
      • 5.3.3.1.2. Inherited Cancer
      • 5.3.3.1.2.1. Global Inherited Cancer Market, 2018 - 2030 (USD Million)
    • 5.3.4. Companion Diagnostics
      • 5.3.4.1. Global Companion Diagnostics Market, 2018 - 2030 (USD Million)
    • 5.3.5. Other Diagnostics
      • 5.3.5.1. Global Other Diagnostics Market, 2018 - 2030 (USD Million)
    • 5.3.6. Research Studies
      • 5.3.6.1. Global Research Studies Market, 2018 - 2030 (USD Million)
  • 5.4. Clinical Investigation
    • 5.4.1. Global Clinical Investigation Market, 2018 - 2030 (USD Million)
    • 5.4.2. Infectious Diseases
      • 5.4.2.1. Global Infectious Diseases Market, 2018 - 2030 (USD Million)
    • 5.4.3. Inherited Diseases
      • 5.4.3.1. Global Inherited Diseases Market, 2018 - 2030 (USD Million)
    • 5.4.4. Idiopathic Diseases
      • 5.4.4.1. Global Idiopathic Diseases Market, 2018 - 2030 (USD Million)
    • 5.4.5. Non-Communicable/Other Diseases
      • 5.4.5.1. Global Non-Communicable/Other Diseases Market, 2018 - 2030 (USD Million)
  • 5.5. Reproductive Health
    • 5.5.1. Global Reproductive Health Market, 2018 - 2030 (USD Million)
    • 5.5.2. NIPT
      • 5.5.2.1. Global NIPT Market, 2018 - 2030 (USD Million)
      • 5.5.2.2. Aneuploidy
      • 5.5.2.2.1. Global Aneuploidy Market, 2018 - 2030 (USD Million)
      • 5.5.2.3. Microdeletions
      • 5.5.2.3.1. Global Microdeletions Market, 2018 - 2030 (USD Million)
    • 5.5.3. PGT
      • 5.5.3.1. Global PGT Market, 2018 - 2030 (USD Million)
    • 5.5.4. Newborn Genetic Screening
      • 5.5.4.1. Global Newborn Genetic Screening Market, 2018 - 2030 (USD Million)
    • 5.5.5. Single Gene Analysis
      • 5.5.5.1. Global Single Gene Analysis Market, 2018 - 2030 (USD Million)
  • 5.6. HLA Typing/Immune System Monitoring
    • 5.6.1. Global HLA Typing/Immune System Monitoring Market, 2018 - 2030 (USD Million)
  • 5.7. Metagenomics, Epidemiology & Drug Development
    • 5.7.1. Global Metagenomics, Epidemiology & Drug Development Market, 2018 - 2030 (USD Million)
  • 5.8. Agrigenomics & Forensics
    • 5.8.1. Global Agrigenomics & Forensics Market, 2018 - 2030 (USD Million)
  • 5.9. Consumer Genomics
    • 5.9.1. Global Consumer Genomics Market, 2018 - 2030 (USD Million)

Chapter 6. Sequencing Market: Workflow Business Analysis

  • 6.1. Sequencing Market: Workflow Market Share Analysis
  • 6.2. Sequencing Market Estimates & Forecast, By Workflow (USD Million)
  • 6.3. Pre-Sequencing
    • 6.3.1. Global Pre-sequencing Market, 2018 - 2030 (USD Million)
  • 6.4. Sequencing
    • 6.4.1. Global Sequencing Market, 2018 - 2030 (USD Million)
  • 6.5. Data Analysis
    • 6.5.1. Global Data Analysis Market, 2018 - 2030 (USD Million)

Chapter 7. Sequencing Market: End-use Business Analysis

  • 7.1. Sequencing market: End-use Market Share Analysis
  • 7.2. Sequencing market Estimates & Forecast, By End-use (USD Million)
  • 7.3. Academic Research
    • 7.3.1. Global Academic Research Market, 2018 - 2030 (USD Million)
  • 7.4. Clinical Research
    • 7.4.1. Global Clinical Research Market, 2018 - 2030 (USD Million)
  • 7.5. Hospitals & Clinics
    • 7.5.1. Global Hospitals & Clinics Market, 2018 - 2030 (USD Million)
  • 7.6. Pharma & Biotech Entities
    • 7.6.1. Global Pharma & Biotech Entities Market, 2018 - 2030 (USD Million)
  • 7.7. Other Users
    • 7.7.1. Global Other Users Market, 2018 - 2030 (USD Million)

Chapter 8. Sequencing Market: Regional Business Analysis

  • 8.1. Sequencing Market Share, By Region, 2023 & 2030
  • 8.2. North America
    • 8.2.1. North America Sequencing market, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Competitive Scenario
      • 8.2.2.3. Target Disease Prevalence
      • 8.2.2.4. Regulatory Framework
      • 8.2.2.5. U.S. Sequencing market, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Competitive Scenario
      • 8.2.3.3. Target Disease Prevalence
      • 8.2.3.4. Regulatory Framework
      • 8.2.3.5. Canada Sequencing market, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Target Disease Prevalence
      • 8.3.2.4. Regulatory Framework
      • 8.3.2.5. UK Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Target Disease Prevalence
      • 8.3.3.4. Regulatory Framework
      • 8.3.3.5. Germany Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Competitive Scenario
      • 8.3.4.3. Target Disease Prevalence
      • 8.3.4.4. Regulatory Framework
      • 8.3.4.5. France Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Competitive Scenario
      • 8.3.5.3. Target Disease Prevalence
      • 8.3.5.4. Regulatory Framework
      • 8.3.5.5. Italy Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Competitive Scenario
      • 8.3.6.3. Target Disease Prevalence
      • 8.3.6.4. Regulatory Framework
      • 8.3.6.5. Spain Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Competitive Scenario
      • 8.3.7.3. Target Disease Prevalence
      • 8.3.7.4. Regulatory Framework
      • 8.3.7.5. Denmark Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Competitive Scenario
      • 8.3.8.3. Target Disease Prevalence
      • 8.3.8.4. Regulatory Framework
      • 8.3.8.5. Sweden Sequencing market, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Competitive Scenario
      • 8.3.9.3. Target Disease Prevalence
      • 8.3.9.4. Regulatory Framework
      • 8.3.9.5. Norway Sequencing market, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Target Disease Prevalence
      • 8.4.2.4. Regulatory Framework
      • 8.4.2.5. Japan Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Target Disease Prevalence
      • 8.4.3.4. Regulatory Framework
      • 8.4.3.5. China Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Target Disease Prevalence
      • 8.4.4.4. Regulatory Framework
      • 8.4.4.5. India Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.5. Australia
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Target Disease Prevalence
      • 8.4.5.4. Regulatory Framework
      • 8.4.5.5. Australia Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.6. Thailand
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Target Disease Prevalence
      • 8.4.6.4. Regulatory Framework
      • 8.4.6.5. Thailand Sequencing market, 2018 - 2030 (USD Million)
    • 8.4.7. South Korea
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Target Disease Prevalence
      • 8.4.7.4. Regulatory Framework
      • 8.4.7.5. South Korea Sequencing market, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Sequencing market, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Target Disease Prevalence
      • 8.5.2.4. Regulatory Framework
      • 8.5.2.5. Brazil Sequencing market, 2018 - 2030 (USD Million)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Target Disease Prevalence
      • 8.5.3.4. Regulatory Framework
      • 8.5.3.5. Mexico Sequencing market, 2018 - 2030 (USD Million)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Target Disease Prevalence
      • 8.5.4.4. Regulatory Framework
      • 8.5.4.5. Argentina Sequencing market, 2018 - 2030 (USD Million)
  • 8.6. MEA
    • 8.6.1. MEA Sequencing market, 2018 - 2030 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Target Disease Prevalence
      • 8.6.2.4. Regulatory Framework
      • 8.6.2.5. South Africa Sequencing market, 2018 - 2030 (USD Million)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Target Disease Prevalence
      • 8.6.3.4. Regulatory Framework
      • 8.6.3.5. Saudi Arabia Sequencing market, 2018 - 2030 (USD Million)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Target Disease Prevalence
      • 8.6.4.4. Regulatory Framework
      • 8.6.4.5. UAE Sequencing market, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Target Disease Prevalence
      • 8.6.5.4. Regulatory Framework
      • 8.6.5.5. Kuwait Sequencing market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Financial Performance
  • 9.2. Participant Categorization
    • 9.2.1. Market Leaders
      • 9.2.1.1. Market share analysis, 2023
  • 9.3. Participant's Overview
    • 9.3.1. Illumina, Inc.
      • 9.3.1.1. Overview
      • 9.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.1.3. Technology Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. F. Hoffman-La Roche Ltd.
      • 9.3.2.1. Overview
      • 9.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.2.3. Technology Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. QIAGEN
      • 9.3.3.1. Overview
      • 9.3.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.3.3. Technology Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Thermo Fisher Scientific, Inc.
      • 9.3.4.1. Overview
      • 9.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.4.3. Technology Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Bio-Rad Laboratories, Inc.
      • 9.3.5.1. Overview
      • 9.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.5.3. Technology Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Oxford Nanopore Technologies
      • 9.3.6.1. Overview
      • 9.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.6.3. Technology Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. PierianDx
      • 9.3.7.1. Overview
      • 9.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.7.3. Technology Benchmarking
      • 9.3.7.4. Strategic Initiatives
    • 9.3.8. Genomatix GmbH
      • 9.3.8.1. Overview
      • 9.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.8.3. Technology Benchmarking
      • 9.3.8.4. Strategic Initiatives
    • 9.3.9. DNASTAR, Inc.
      • 9.3.9.1. Overview
      • 9.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.9.3. Technology Benchmarking
      • 9.3.9.4. Strategic Initiatives
    • 9.3.10. Perkin Elmer, Inc.
      • 9.3.10.1. Overview
      • 9.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.10.3. Technology Benchmarking
      • 9.3.10.4. Strategic Initiatives
    • 9.3.11. Eurofins GATC Biotech GmbH
      • 9.3.11.1. Overview
      • 9.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.11.3. Technology Benchmarking
      • 9.3.11.4. Strategic Initiatives
    • 9.3.12. BGI
      • 9.3.12.1. Overview
      • 9.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.3.12.3. Technology Benchmarking
      • 9.3.12.4. Strategic Initiatives
  • 9.4. Strategy Mapping
    • 9.4.1. Expansion
    • 9.4.2. Acquisition
    • 9.4.3. Collaborations
    • 9.4.4. Product/service launch
    • 9.4.5. Partnerships
    • 9.4.6. Others

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 4 Global sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 5 Global sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 6 Global sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Global sequencing market, by region, 2018 - 2030 (USD Million)
  • Table 8 North America sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 10 North America sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 12 North America sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 U.S. sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 14 U.S. sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 15 U.S. sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 16 U.S. sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 Canada sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 18 Canada sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 19 Canada sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 20 Canada sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Europe sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 22 Europe sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 23 Europe sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 24 Europe sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 25 Europe sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 27 UK sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 29 UK sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Germany sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 31 Germany sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 32 Germany sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 33 Germany sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 France sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 35 France sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 36 France sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 37 France sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Italy sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 39 Italy sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 40 Italy sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 41 Italy sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 42 Spain sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 43 Spain sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 44 Spain sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Spain sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Denmark sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 47 Denmark sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 48 Denmark sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 49 Denmark sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Sweden sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 51 Sweden sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 52 Sweden sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 53 Sweden sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Norway sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 55 Norway sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 56 Norway sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Norway sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Japan sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 64 Japan sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Japan sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 66 Japan sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 China sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 68 China sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 69 China sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 70 China sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 India sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 72 India sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 73 India sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 74 India sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Australia sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 76 Australia sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Australia sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 78 Australia sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Thailand sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 80 Thailand sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Thailand sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 82 Thailand sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Korea sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 84 South Korea sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 85 South Korea sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 86 South Korea sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 87 Latin America sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 88 Latin America sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 89 Latin America sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Latin America sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 91 Latin America sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Brazil sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 93 Brazil sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 94 Brazil sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 95 Brazil sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 Mexico sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 97 Mexico sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 98 Mexico sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 99 Mexico sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 100 Argentina sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 101 Argentina sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 102 Argentina sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 103 Argentina sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa sequencing market, by country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 109 South Africa sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 110 South Africa sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 111 South Africa sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 112 South Africa sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 117 UAE sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 118 UAE sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 119 UAE sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 120 UAE sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 121 Kuwait sequencing market, by product & services, 2018 - 2030 (USD Million)
  • Table 122 Kuwait sequencing market, by application, 2018 - 2030 (USD Million)
  • Table 123 Kuwait sequencing market, by workflow, 2018 - 2030 (USD Million)
  • Table 124 Kuwait sequencing market, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Participant's overview
  • Table 126 Financial performance
  • Table 127 Key companies undergoing expansions
  • Table 128 Key companies undergoing acquisitions
  • Table 129 Key companies undergoing collaborations
  • Table 130 Key companies launching new products/services
  • Table 131 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Sequencing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook
  • Fig. 13 Related/ancillary market outlook
  • Fig. 14 Genomics - Industry value chain analysis
  • Fig. 15 Sequencing market driver analysis
  • Fig. 16 Sequencing market restraint analysis
  • Fig. 17 Sequencing market: Porter's analysis
  • Fig. 18 Sequencing market: Product & services outlook and key takeaways
  • Fig. 19 Sequencing market: Product & services market share analysis, 2023-2030
  • Fig. 20 Global sequencing by Platform market, 2018 - 2030 (USD Million)
  • Fig. 21 Global sequencing by 1st Generation of sequencing device market, 2018 - 2030 (USD Million)
  • Fig. 22 Global sequencing by 2nd Generation of sequencing device market, 2018 - 2030 (USD Million)
  • Fig. 23 Global sequencing by 3rd Generation of sequencing device market, 2018 - 2030 (USD Million)
  • Fig. 24 Global sequencing by Consumables market, 2018 - 2030 (USD Million)
  • Fig. 25 Global sequencing by Kits market, 2018 - 2030 (USD Million)
  • Fig. 26 Global sequencing by DNA Library Preparation market, 2018 - 2030 (USD Million)
  • Fig. 27 Global sequencing by RNA Library Preparation market, 2018 - 2030 (USD Million)
  • Fig. 28 Global sequencing by Target enrichment market, 2018 - 2030 (USD Million)
  • Fig. 29 Global sequencing by Library quantification market, 2018 - 2030 (USD Million)
  • Fig. 30 Global sequencing by Purification & quality control market, 2018 - 2030 (USD Million)
  • Fig. 31 Global sequencing by Others market, 2018 - 2030 (USD Million)
  • Fig. 32 Global sequencing by Reagents market, 2018 - 2030 (USD Million)
  • Fig. 33 Global sequencing by Sample Prep market, 2018 - 2030 (USD Million)
  • Fig. 34 Global sequencing by Library preparation and amplification market, 2018 - 2030 (USD Million)
  • Fig. 35 Global sequencing by Sequencing market, 2018 - 2030 (USD Million)
  • Fig. 36 Global sequencing by Accessories market, 2018 - 2030 (USD Million)
  • Fig. 37 Global sequencing by Collection tubes market, 2018 - 2030 (USD Million)
  • Fig. 38 Global sequencing by Plates market, 2018 - 2030 (USD Million)
  • Fig. 39 Global sequencing by Others market, 2018 - 2030 (USD Million)
  • Fig. 40 Global sequencing by Services market, 2018 - 2030 (USD Million)
  • Fig. 41 Global sequencing by Software market, 2018 - 2030 (USD Million)
  • Fig. 42 Sequencing market: Application outlook and key takeaways
  • Fig. 43 Sequencing market: Application market share analysis, 2023-2030
  • Fig. 44 Global sequencing by Oncology market, 2018 - 2030 (USD Million)
  • Fig. 45 Global sequencing by Diagnostics and Screening market, 2018 - 2030 (USD Million)
  • Fig. 46 Global sequencing by Oncology Screening market, 2018 - 2030 (USD Million)
  • Fig. 47 Global sequencing by Sporadic Cancer market, 2018 - 2030 (USD Million)
  • Fig. 48 Global sequencing by Inherited Cancer market, 2018 - 2030 (USD Million)
  • Fig. 49 Global sequencing by Companion Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 50 Global sequencing by Other Diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 51 Global sequencing by Research Studies market, 2018 - 2030 (USD Million)
  • Fig. 52 Global sequencing by Clinical Investigation market, 2018 - 2030 (USD Million)
  • Fig. 53 Global sequencing by Infectious Diseases market, 2018 - 2030 (USD Million)
  • Fig. 54 Global sequencing by Inherited Diseases market, 2018 - 2030 (USD Million)
  • Fig. 55 Global sequencing by Idiopathic Diseases market, 2018 - 2030 (USD Million)
  • Fig. 56 Global sequencing by Non-Communicable/Other Diseases market, 2018 - 2030 (USD Million)
  • Fig. 57 Global sequencing by Reproductive Health market, 2018 - 2030 (USD Million)
  • Fig. 58 Global sequencing by NIPT market, 2018 - 2030 (USD Million)
  • Fig. 59 Global sequencing by Aneuploidy market, 2018 - 2030 (USD Million)
  • Fig. 60 Global sequencing by Microdeletions market, 2018 - 2030 (USD Million)
  • Fig. 61 Global sequencing by PGT market, 2018 - 2030 (USD Million)
  • Fig. 62 Global sequencing by Newborn Genetic Screening market, 2018 - 2030 (USD Million)
  • Fig. 63 Global sequencing by Single Gene Analysis market, 2018 - 2030 (USD Million)
  • Fig. 64 Global sequencing by HLA Typing/Immune System Monitoring market, 2018 - 2030 (USD Million)
  • Fig. 65 Global sequencing by Metagenomics, Epidemiology & Drug Development market, 2018 - 2030 (USD Million)
  • Fig. 66 Global sequencing by Agrigenomics & Forensics market, 2018 - 2030 (USD Million)
  • Fig. 67 Global sequencing by Consumer Genomics market, 2018 - 2030 (USD Million)
  • Fig. 68 Sequencing market: Workflow outlook and key takeaways
  • Fig. 69 Sequencing market: Workflow market share analysis, 2023-2030
  • Fig. 70 Global sequencing by Pre-Sequencing market, 2018 - 2030 (USD Million)
  • Fig. 71 Global sequencing by Sequencing market, 2018 - 2030 (USD Million)
  • Fig. 72 Global sequencing by Data Analysis market, 2018 - 2030 (USD Million)
  • Fig. 73 Sequencing market: End-use outlook and key takeaways
  • Fig. 74 Sequencing market: End-use market share analysis, 2023-2030
  • Fig. 75 Global sequencing by Academic Research market, 2018 - 2030 (USD Million)
  • Fig. 76 Global sequencing by Clinical Research market, 2018 - 2030 (USD Million)
  • Fig. 77 Global sequencing by Hospitals & Clinics market, 2018 - 2030 (USD Million)
  • Fig. 78 Global sequencing by Pharma & Biotech Entities market, 2018 - 2030 (USD Million)
  • Fig. 79 Global sequencing by Other users market, 2018 - 2030 (USD Million)
  • Fig. 80 Regional marketplace: Key takeaways
  • Fig. 81 Regional marketplace: Key takeaways
  • Fig. 82 North America sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 U.S. key country dynamics
  • Fig. 84 U.S. sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Canada key country dynamics
  • Fig. 86 Canada sequencing market, 2018 - 2030 (USD Million)
  • Fig. 87 Europe sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 UK key country dynamics
  • Fig. 89 UK sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 90 Germany key country dynamics
  • Fig. 91 Germany sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 France key country dynamics
  • Fig. 93 France sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 94 Italy key country dynamics
  • Fig. 95 Italy sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Spain key country dynamics
  • Fig. 97 Spain sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 98 Denmark key country dynamics
  • Fig. 99 Denmark sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Sweden key country dynamics
  • Fig. 101 Sweden sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 102 Norway key country dynamics
  • Fig. 103 Norway sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Asia-Pacific sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 105 Japan key country dynamics
  • Fig. 106 Japan sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 China key country dynamics
  • Fig. 108 China sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 109 India key country dynamics
  • Fig. 110 India sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Australia key country dynamics
  • Fig. 112 Australia sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 113 Thailand key country dynamics
  • Fig. 114 Thailand sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 South Korea key country dynamics
  • Fig. 116 South Korea sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 117 Latin America sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 118 Brazil key country dynamics
  • Fig. 119 Brazil sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 120 Mexico key country dynamics
  • Fig. 121 Mexico sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 122 Argentina key country dynamics
  • Fig. 123 Argentina sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 124 MEA sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 South Africa key country dynamics
  • Fig. 126 South Africa sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 127 Saudi Arabia key country dynamics
  • Fig. 128 Saudi Arabia sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 UAE key country dynamics
  • Fig. 130 UAE sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 131 Kuwait key country dynamics
  • Fig. 132 Kuwait sequencing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Key company categorization
  • Fig. 134 Company market positioning
  • Fig. 135 Market participant categorization
  • Fig. 136 Strategy framework